Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding

 Abstract

Many neurodegenerative disorders share common features including the accumulation of aggregated misfolded proteins, neuroinflammation and apoptotic neuronal death. While the contributions of each of these individual elements to neuronal death remain unclear, a commonly used antibiotic, minocycline, has been shown to reduce the progression and severity of disease in several models of neurodegeneration by variously downregulating these molecular pathways. Here we discuss the evidence for the potential of minocycline as a broad-specificity therapeutic agent for those neurodegenerative diseases that are characterised by the presence of misfolded proteins.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
78 - 83
doi
10.4161/pri.3.2.8820
Type
Commentary & View
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding